• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYMATESE EVOLYSSE SMOOTH; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYMATESE EVOLYSSE SMOOTH; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number EVO-SMTH-01
Medical Device Problem Codes Off-Label Use (1494); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Codes Inflammation (1932); Nodule (4551)
Date of Event 06/25/2025
Type of Reportable Event Serious Injury
Event or Problem Description
A healthcare professional reported injecting 0.8ml of evolysse smooth into the upper and lower lips of a patient.Approximately 8 weeks post injection, the patient experienced lumps.The hcp dissolved the lumps with hyaluronidase with some difficulty.The manufacturer provided syringe was not used.
 
Additional Manufacturer Narrative
The product was injected into the patient and is not available for return.The production records for the lot were reviewed, and no deviations were found during production that would relate to the reported event; the device met all specifications.Inflammation such as swelling or redness may develop near the dermal filler injection site following viral or bacterial illnesses or infections, vaccinations, or dental procedures.In some cases, side effects may emerge weeks, months, or years later.This is a known potential adverse event addressed in the product labeling and risk management file.The product was used off-label in the lip region.We cannot rule out that this may have contributed to the reported event.Complaints: (b)(4).Capa: 25002.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLYSSE SMOOTH
Common Device Name
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
SYMATESE
zi les troques
chapnost, auvergne-rhone-alpes 69630
FR  69630
Manufacturer (Section G)
SYMATESE
zi les troques
chapnost, auvergne-rhone-alpes 69630
FR   69630
Manufacturer Contact
laurence hermitte
zi les troques
chapnost, auvergne-rhone-alpes 69630
FR   69630
MDR Report Key23620920
Report Number3003672980-2025-00157
Device Sequence Number9052071
Product Code LMH
UDI-Device Identifier03760172161271
UDI-Public(01)03760172161271(17)270228(10)S2251050161
Combination Product (Y/N)Y
Initial Reporter StateID
Initial Reporter CountryUS
PMA/510(K) Number
P240022
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Distributor
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 11/21/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberEVO-SMTH-01
Device Lot NumberS2251050161
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/16/2025
Initial Report FDA Received Date11/21/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/21/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age32 YR
Patient SexFemale
-
-